4.7 Review

The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 53, 期 3, 页码 285-305

出版社

ELSEVIER
DOI: 10.1016/S0169-409X(01)00233-2

关键词

Liposomes; hyperthermia; doxorubicin; FaDu tumors; lysolipid

资金

  1. NCI NIH HHS [CA 40355, CA 87630, CA 42745] Funding Source: Medline
  2. NIGMS NIH HHS [GM 40162] Funding Source: Medline

向作者/读者索取更多资源

Our laboratories have been working together in close collaboration for over 10 years concerning the design and performance of lipid-based drug delivery systems. Over the past 3 years we have conceived of, developed, and tested pre-clinically, a new liposome-based temperature-sensitive drug delivery system for the treatment of solid tumors. This work is reported in a series of four publications: 'J. Liposome Res. 9 (1999) 491; Cancer Res. Adv. Brief 60(5) (2000) 1197; Cancer Res. 6(9) (2000) 748; and Cancer Res. 60 (2000) 6950'. Following a brief introduction concerning the motivations behind the work, this article will review these studies, including some of our earlier work that led to these ideas, and will present the rational design of the new liposome formulation from a materials engineering perspective. (C) 2001 Published by Elsevier Science B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据